US Broker Ratings

Insmed Incorporated (INSM) Stock Analysis: Exploring a 111.76% Potential Upside in the Biotech Sector

Insmed Incorporated (NASDAQ: INSM) stands out in the biotechnology sector with its promising pipeline of therapies targeting serious and rare diseases. With a market capitalization of..

West Pharmaceutical Services (WST) Stock Analysis: A 12% Upside Potential Amid Robust Revenue Growth

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Option Care Health, Inc. (OPCH) Stock Analysis: 42% Potential Upside Beckons Investors

Option Care Health, Inc. (NASDAQ: OPCH) stands at the forefront of the healthcare sector, particularly within the medical care facilities industry, offering a compelling investment opportunity..

Merck & Co., Inc. (MRK) Stock Analysis: Evaluating a 7.41% Upside Potential Amid Strong Buy Ratings

Merck & Co., Inc. (NYSE: MRK) stands as a cornerstone in the healthcare sector, with a commanding market capitalization of $298.33 billion. Renowned for its robust..

DexCom, Inc. (DXCM): Investor Outlook Reveals 13.92% Potential Upside in Continuous Glucose Monitoring Market

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector specializing in medical devices, continues to command attention with its cutting-edge continuous glucose monitoring (CGM) systems...

Quest Diagnostics (DGX) Stock Analysis: Strong Upside Potential with Analyst Consensus

Investors seeking a solid opportunity in the healthcare sector might want to consider Quest Diagnostics Incorporated (NYSE: DGX), a leading player in the diagnostics and research..

Intuitive Surgical, Inc. (ISRG) Stock Report: Analyzing the 33.93% Potential Upside with Strong Buy Ratings

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a formidable player in the medical instruments and supplies industry, with a market capitalization of $149.48 billion. Based in..

Globus Medical, Inc. (GMED) Stock Analysis: A 37.5% Potential Upside Captures Investor Attention

Globus Medical, Inc. (NYSE: GMED), a key player in the healthcare sector specializing in medical devices, stands out with its robust market presence and promising growth..

GSK plc (GSK) Stock Analysis: Evaluating a Strong 12.46% Potential Upside in the Healthcare Sector

GSK plc (NYSE: GSK), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth outlook. With..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with a 36.60% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV) is capturing investor attention in the healthcare sector with its ambitious approach to drug development and a significant potential upside of..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Promising Biotechnology Leader with 47% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a formidable player in the biotechnology sector, known for its pioneering work in ribonucleic acid interference (RNAi) therapeutics. With..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Novartis AG (NVS) Stock Analysis: Evaluating Growth Potential with a 3.15% Upside

Novartis AG (NYSE: NVS), a Swiss pharmaceutical giant, commands a formidable presence in the healthcare sector, specifically within the drug manufacturing industry. As one of the..

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 35% Potential Upside with Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector as a formidable player in the medical care facilities industry, boasting a market capitalization of..

Repligen Corporation (RGEN) Stock Analysis: Unlocking a 43.98% Upside in Bioprocessing Innovation

Investors with a keen interest in the healthcare sector’s innovative frontier may find Repligen Corporation (NASDAQ: RGEN) a compelling prospect. With a market capitalization of $6.9..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 12.34% Potential Upside Amid Strategic Collaborations

Biogen Inc. (NASDAQ: BIIB), a titan in the healthcare sector, particularly in the drug manufacturing industry, is capturing investor attention with a compelling potential upside of..

Natera, Inc. (NTRA) Stock Analysis: Insights into a High-Growth Diagnostics Leader with a 20% Upside Potential

Natera, Inc. (NASDAQ: NTRA), a prominent player in the diagnostics and research sector, is drawing investor attention with its innovative molecular testing services and strong revenue..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Exploring a 39% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing the attention of investors with its focus on groundbreaking therapies for metabolic..

Becton, Dickinson and Company (BDX) Stock Analysis: Unpacking a 19.89% Potential Upside

Investors eyeing opportunities in the healthcare sector may find Becton, Dickinson and Company (NYSE: BDX) a compelling option. With a robust market cap of $41.65 billion,..

Agilent Technologies, Inc. (A) Stock Analysis: Healthcare Giant with 18.87% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, is renowned for its innovative solutions in the diagnostics and research industry. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds